Loading…
Point mutation in the Virbrio cholerae O139 cef (CHO cell elongating factor) gene alters the substrate specificity of its product
Sequencing of the cef (CHO cell elongating factor) gene of Vibrio cholerae serogroup O139 revealed one nucleotide substitution (T to C at nucleotide 2015) as compared to cef of classical V. cholerae O1 and two substitutions (GT to AC at nucleotides 2014–2015) as compared to cef of V. cholerae O1 El...
Saved in:
Published in: | Russian journal of genetics 2012-02, Vol.48 (2), p.245-248 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Sequencing of the
cef
(CHO cell elongating factor) gene of
Vibrio cholerae
serogroup O139 revealed one nucleotide substitution (T to C at nucleotide 2015) as compared to
cef
of classical
V. cholerae
O1 and two substitutions (GT to AC at nucleotides 2014–2015) as compared to
cef
of
V. cholerae
O1 El Tor. A comparative bioinformatic analysis showed that the substitution determines a threonine residue in position 672 of the Cef protein, while this position is occupied by an isoleucine residue in the classical strains and a valine residue in the El Tor strains. The latter two amino acids are hydrophobic, while threonine is hydrophilic, having a polar R group. The nonsynonymous substitution affects the predicted secondary and, probably, tertiary structures of the Cef-O139 protein and explained our previous finding that the protein fails to degrade tributyrin, while retaining the tweenase activity spectrum and all other characteristics. It cannot be excluded that the inability of Cef-O139 to cleave triglycerides, along with other genetic specifics, contribute to the fact that the O139 serogroup has been supplanted from a dominating position in etiology of cholera by the El Tor biotype. The nucleotide sequence of the
V. cholerae
O139
cef
gene and the deduced amino acid sequence of its product are reported for the first time and were deposited in GenBank under accession nos. JF499787 and AEC04822.1, respectively. |
---|---|
ISSN: | 1022-7954 1608-3369 |
DOI: | 10.1134/S1022795412020123 |